Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Moving Clinical Genomics Beyond the Hype
Necessary Actions Include an Evidence Base as well as Physician, Patient, and Payer Education
- More than a decade after the successful mapping of the human genome, clinical genomics is starting to permeate important parts of patient care and ripple throughout the entire U.S. healthcare system. This increased adoption is partly due to growing acceptance of useful interventions, but it is also due ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.